Renal Disease Market Research Report Information by Disease Type (Chronic Kidney Disease, End-Stage Renal Disease), by Treatment Type (Dialysis, Medication, Kidney Transplantation), by End User (Dialysis Centers, Hospital & Clinics, Research and Academic Institutes), and By Region (North America, Europe, Asia-Pacific, and Rest of The World) – Forecast Till 2030
Renal disease, also known as kidney disease, encompasses a wide range of conditions that affect the proper functioning of the kidneys. These conditions can vary in severity and may result from various factors such as diabetes, hypertension, autoimmune disorders, genetic predisposition, and more. The renal disease market is a crucial segment within the healthcare industry, as kidney-related disorders pose significant health challenges worldwide. This overview provides insights into the current state of the renal disease market, including key trends, challenges, and opportunities.
The Renal Disease Market industry is projected to grow from USD 42.36 billion in 2023 to USD 89.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.20 % during the forecast period (2023 – 2030). Renal diseases are also known by a different name, kidney diseases. The occurrence of the disease can happen due to several reasons like pollution, changing lifestyle, high intake of protein, and others.
The detailed report of MRFR provides light on the impact heaved upon the sector by rising in the geriatric population, better diagnostic procedures, growing awareness regarding the disease, and others. Diabetes and hypertension can also impact market growth. However, high healthcare costs and stringent regulation costs can pull back the renal disease market growth.
Get Free Sample PDF Brochure @
The global renal disease market can be discussed on a platform provided by segments like disease type, treatment type, and end user. This segmentation has data and figures on several aspects with potential to trigger market growth.
By treatment type, the global market report on renal disease includes medications, dialysis, and kidney transplantation. Growing awareness of the disease is providing opportunities regarding better treatment and is taking these segments ahead.
By end user, the global renal disease market report can be segmented into hospitals & clinics, dialysis centers, and research & academic institutes. The hospitals & clinics segment would score notably higher than in previous years.
Several players showing interest in the renal disease market are Amgen Inc. (US), Abbott (US), Bristol-Myers Squibb Company (US), AstraZeneca (US), Fresenius Medical Care AG & Co. KGaA (UK), F. Hoffmann-La Roche Ltd (Switzerland), Keryx Biopharmaceuticals, Inc (US), GlaxoSmithKline PLC (UK), Pfizer Inc. (US), Sanofi SA (France), Novartis AG (Switzerland), Kissei Pharmaceutical Co., Ltd (Japan), and Teva Pharmaceutical Industries Ltd (Israel). MRFR’s recording of these companies in the report has its focus set on various tactical moves that they implement to make their stance strong. This also provides inputs regarding how the market is going to act in the coming years.
The Americas have a better potential to perform well among its peers in the renal disease market. The regional market had the largest market share of which the lion’s share comes from North America where the US and Canada contribute the most. These two countries are known for their extensive market contribution. This has been possible for the countries as they have robust infrastructure, strong reimbursement policies to cover the needs of the people, a better influx of investment for research & development purpose and others. The rising geriatric population is also registering growth in numbers for renal diseases.
Browse In-depth Market Research Report (157 Pages) on Renal disease:
Europe’s growth in terms of the market for renal diseases is quite extraordinary. As per the reports published in 2015 in the European Renal Association’s annual report, 10% of the European population are affected by various forms of renal diseases. Better availability of diagnostic procedures can also make sure that the market for renal disease gains better prospects. The Asia Pacific region has a vast population that can trigger the growth of the market. This has the potential of emerging as the fastest-growing region in the coming years. Countries like China, India, and South Korea are impacting the market with high investment. This region is also profiting much as a destination for outsourcing of clinical trials, drug manufacturing, and pathology testing.
Discover More Research Reports on Healthcare Industry by Market Research Future:
Brain Aneurysm Treatment Market Research Report Information: By Type (Surgery (Surgical Clipping, Endovascular Coiling), Medication (Antacid, Stool Softener)), Condition (Unruptured Aneurysm, Ruptured Aneurysm), End User (Hospitals, Clinics) – Global Forecast till 2030
Primary Osteoarthritis Market Research Report Information By Type (Knee, Hand, Neck, Hip, Wrist, Spinal, and Shoulder Osteoarthritis), Product Type, Drug Class (Combination Drug, LTA, ICS, SABA, LABA), Route of Administration, End User – Global Forecast till 2030
Nuclear Medicine Market Research Report Information By Product Type ( Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals [ Tc-99m, TI-201, Ga-67, I-123, and Others], Pet Radiopharmaceuticals [Tc-99m, TI-201, Ga-67, I-123, and Others]), Therapeutic Nuclear Medicine (Alpha Emitters[ Ra-223], Beta Emitters[I-131, Y-90, Sm-153, Lu-177, Re-186, and Others]), Brachytherapy Isoptopes [Ir-192, I-125, Pd-103, Cs-131, and Others]), By Application (Diagnostic Applications SPECT Applications[Cardiology, Neurology, Lymphoma, Thyroid, and Others]
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.